Severin Schwan: Full interview

Roche is keen to build on its stable of cancer treatments by developing diagnostics that will lead to more effective medicines. Roche's chief executive Severin Schwan tells Andrew Jack, pharmaceuticals correspondent, about the Swiss pharmaceutical group's diversification away from its oncology core.